Cargando…

Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?

The identification of the most efficient method for whole central nervous system targeting that is translatable to humans and the safest route of adeno-associated virus (AAV) administration is a major concern for future applications in clinics. Additionally, as many AAV serotypes were identified for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bey, Karim, Deniaud, Johan, Dubreil, Laurence, Joussemet, Béatrice, Cristini, Joseph, Ciron, Carine, Hordeaux, Juliette, Le Boulc’h, Morwenn, Marche, Kevin, Maquigneau, Maud, Guilbaud, Michaël, Moreau, Rosalie, Larcher, Thibaut, Deschamps, Jack-Yves, Fusellier, Marion, Blouin, Véronique, Sevin, Caroline, Cartier, Nathalie, Adjali, Oumeya, Aubourg, Patrick, Moullier, Philippe, Colle, Marie-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184633/ https://www.ncbi.nlm.nih.gov/pubmed/32355866 http://dx.doi.org/10.1016/j.omtm.2020.04.001

Ejemplares similares

Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats
por: Bucher, T, et al.
Publicado: (2014)

Pretherapeutic Imaging for Axillary Staging in Breast Cancer: A Systematic Review and Meta-Analysis of Ultrasound, MRI and FDG PET
por: Le Boulc’h, Morwenn, et al.
Publicado: (2021)

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease
por: Hordeaux, J., et al.
Publicado: (2017)

Chemical modification of the adeno-associated virus capsid to improve gene delivery
por: Mével, Mathieu, et al.
Publicado: (2019)

Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls
por: François, Achille, et al.
Publicado: (2018)

Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates
por: Le Guiner, Caroline, et al.
Publicado: (2014)

Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II)
por: Lagalice, Lydie, et al.
Publicado: (2018)

EUCLID Feedback
por: LE BOULC'H, Quentin, et al.
Publicado: (2018)

Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer
por: Moreau, Aurélie, et al.
Publicado: (2014)

Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits
por: Lorant, Judith, et al.
Publicado: (2018)

Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
por: Vandamme, Céline, et al.
Publicado: (2017)

Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8(+) T Cells in Human Donors Allows the Detection of a T(EMRA) Subpopulation
por: Vandamme, Céline, et al.
Publicado: (2020)

AAVrh10 vector corrects pathology in animal models of GM1 gangliosidosis and achieves widespread distribution in the CNS of nonhuman primates
por: Hocquemiller, Michaël, et al.
Publicado: (2022)

Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates
por: Borel, Florie, et al.
Publicado: (2016)

Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy
por: Le Guiner, Caroline, et al.
Publicado: (2023)

Risk Mitigation of Immunogenicity: A Key to Personalized Retinal Gene Therapy
por: Varin, Juliette, et al.
Publicado: (2021)

Development of capsid- and genome-modified optimized AAVrh74 vectors for muscle gene therapy
por: Shoti, Jakob, et al.
Publicado: (2023)

AAV8 locoregional delivery induces long-term expression of an immunogenic transgene in macaques despite persisting local inflammation
por: Gernoux, Gwladys, et al.
Publicado: (2021)

Persistent Expression of Biologically Active Anti-HER2 Antibody by AAVrh.10-mediated Gene Transfer
por: Wang, Guoqing, et al.
Publicado: (2010)

Can early treatment of twitcher mice with high dose AAVrh10-GALC eliminate the need for BMT?
por: Rafi, Mohammad A, et al.
Publicado: (2021)

Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy
por: Homs, Judit, et al.
Publicado: (2014)

Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice
por: Tanguy, Yannick, et al.
Publicado: (2015)

Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
por: Butala-Flores, Elizabeth, et al.
Publicado: (2023)

Intravitreal air tamponade after AAV2 subretinal injection modifies retinal EGFP distribution
por: Ducloyer, Jean-Baptiste, et al.
Publicado: (2023)

Simple approach for the fabrication of PEDOT-coated Si nanowires
por: Zhu, Mingxuan, et al.
Publicado: (2015)

Different protein composition and functional properties of adeno-associated virus-6 vector manufactured from the culture medium and cell lysates
por: Denard, Jerome, et al.
Publicado: (2014)

Liver-Specific Transcriptional Modules Identified by Genome-Wide In Silico Analysis Enable Efficient Gene Therapy in Mice and Non-Human Primates
por: Chuah, Marinee K, et al.
Publicado: (2014)

AAVrh.10-mediated Genetic Delivery of Bevacizumab to the Pleura to Provide Local Anti-VEGF to Suppress Growth of Metastatic Lung Tumors
por: Watanabe, Masaki, et al.
Publicado: (2010)

AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains
por: Hocquemiller, Michaël, et al.
Publicado: (2019)

Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy
por: Goedeker, Natalie L., et al.
Publicado: (2023)

TRPC3, but not TRPC1, as a good therapeutic target for standalone or complementary treatment of DMD
por: Creisméas, Anna, et al.
Publicado: (2021)

Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency
por: Lam, Patricia, et al.
Publicado: (2022)

Quantification of human mature frataxin protein expression in nonhuman primate hearts after gene therapy
por: Blair, Ian, et al.
Publicado: (2023)

An Isolated Limb Infusion Method Allows for Broad Distribution of rAAVrh74.MCK.GALGT2 to Leg Skeletal Muscles in the Rhesus Macaque
por: Xu, Rui, et al.
Publicado: (2018)

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial
por: Mendell, Jerry R., et al.
Publicado: (2020)

Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Potter, Rachael A., et al.
Publicado: (2021)

Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy
por: Willcocks, Rebecca J., et al.
Publicado: (2021)

Selective transduction of cerebellar Purkinje and granule neurons using delivery of AAV-PHP.eB and AAVrh10 vectors at axonal terminal locations
por: Surdyka, Magdalena, et al.
Publicado: (2022)

Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants
por: Li, Minchao, et al.
Publicado: (2022)

The protooncogene Vav1 regulates murine leukemia virus-induced T-cell leukemogenesis
por: Kaminski, Sandra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kkrbp4824c6dhd70l2dcivqlm1